Cargando…

Neuromodulation in Inflammatory Skin Disease

Inflammatory skin diseases are difficult to treat because of a lack of available treatment options for severe disease. However, recent advances have shown that vagus nerve stimulation can be used to decrease inflammation and reduce disease severity in rheumatoid arthritis and inflammatory bowel dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Eric J., Sekhon, Sahil, Beck, Kristen M., Bhutani, Tina, Koo, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825332/
https://www.ncbi.nlm.nih.gov/pubmed/29427206
http://dx.doi.org/10.1007/s13555-018-0227-4
_version_ 1783302174018633728
author Yang, Eric J.
Sekhon, Sahil
Beck, Kristen M.
Bhutani, Tina
Koo, John
author_facet Yang, Eric J.
Sekhon, Sahil
Beck, Kristen M.
Bhutani, Tina
Koo, John
author_sort Yang, Eric J.
collection PubMed
description Inflammatory skin diseases are difficult to treat because of a lack of available treatment options for severe disease. However, recent advances have shown that vagus nerve stimulation can be used to decrease inflammation and reduce disease severity in rheumatoid arthritis and inflammatory bowel disease. Changes in cytokine profiles observed in these studies are similar to those seen with use of biologics in inflammatory skin disease, suggesting that they act along similar pathways to disrupt chronic inflammation and treat inflammatory disease. This commentary explores the existing evidence demonstrating the efficacy of neuromodulation in inflammatory disease, and outlines reasons why these findings could translate to the dermatology setting to treat inflammatory skin disease.
format Online
Article
Text
id pubmed-5825332
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-58253322018-02-28 Neuromodulation in Inflammatory Skin Disease Yang, Eric J. Sekhon, Sahil Beck, Kristen M. Bhutani, Tina Koo, John Dermatol Ther (Heidelb) Commentary Inflammatory skin diseases are difficult to treat because of a lack of available treatment options for severe disease. However, recent advances have shown that vagus nerve stimulation can be used to decrease inflammation and reduce disease severity in rheumatoid arthritis and inflammatory bowel disease. Changes in cytokine profiles observed in these studies are similar to those seen with use of biologics in inflammatory skin disease, suggesting that they act along similar pathways to disrupt chronic inflammation and treat inflammatory disease. This commentary explores the existing evidence demonstrating the efficacy of neuromodulation in inflammatory disease, and outlines reasons why these findings could translate to the dermatology setting to treat inflammatory skin disease. Springer Healthcare 2018-02-09 /pmc/articles/PMC5825332/ /pubmed/29427206 http://dx.doi.org/10.1007/s13555-018-0227-4 Text en © The Author(s) 2018 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Commentary
Yang, Eric J.
Sekhon, Sahil
Beck, Kristen M.
Bhutani, Tina
Koo, John
Neuromodulation in Inflammatory Skin Disease
title Neuromodulation in Inflammatory Skin Disease
title_full Neuromodulation in Inflammatory Skin Disease
title_fullStr Neuromodulation in Inflammatory Skin Disease
title_full_unstemmed Neuromodulation in Inflammatory Skin Disease
title_short Neuromodulation in Inflammatory Skin Disease
title_sort neuromodulation in inflammatory skin disease
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825332/
https://www.ncbi.nlm.nih.gov/pubmed/29427206
http://dx.doi.org/10.1007/s13555-018-0227-4
work_keys_str_mv AT yangericj neuromodulationininflammatoryskindisease
AT sekhonsahil neuromodulationininflammatoryskindisease
AT beckkristenm neuromodulationininflammatoryskindisease
AT bhutanitina neuromodulationininflammatoryskindisease
AT koojohn neuromodulationininflammatoryskindisease